AIROS Medical Launches Innovative ARTAIRA Compression Device
AIROS Medical, Inc., a leader in developing advanced medical technology focused on compression therapy systems, is excited to unveil its latest device, the ARTAIRA Arterial Compression Device. This FDA-cleared device offers a non-invasive solution aimed at increasing blood flow to the lower extremities, bringing relief to patients suffering from symptoms associated with Peripheral Arterial Disease (PAD).
Revolutionary Approach to Peripheral Arterial Disease
Peripheral Arterial Disease is a serious condition characterized by narrowed arteries which significantly restrict blood flow to the limbs. The result can be painful and poses risks of serious health complications, including infections and even amputation. A recent global projection indicates that cases of PAD could surge to over 360 million by the year 2050, emphasizing the urgent need for effective treatment solutions.
How ARTAIRA Works
The ARTAIRA device operates through a sophisticated pneumatic compression mechanism. It utilizes a two-chamber garment worn on the legs, where air compression cycles inflate and deflate in a sequence to exert controlled pressure. This enhances circulation and alleviates symptoms, facilitating better healing for those experiencing complications related to PAD.
Designed for Patient Comfort and Ease
Developed with patient comfort in mind, the ARTAIRA device is lightweight at just seven pounds and designed for use at home. Its user-friendly interface includes a color LCD screen that simplifies monitoring of pressure levels and treatment times, making it accessible for all patients, including those who may not be technologically inclined.
AIROS Medical’s Commitment to Patient Care
AIROS Medical has a well-established reputation for providing innovative solutions for chronic venous insufficiency and lymphedema. With the introduction of ARTAIRA, the company is poised to extend its impact within the realm of vascular health. Darren M. Behuniak, the Chief Operating Officer, expresses the company’s dedication: "Our goal is to harness our pneumatic compression technology to benefit a wider patient population. We aim to improve quality of life through enhanced circulation and healing."
Insurance Coverage and Education Initiatives
The ARTAIRA device is prescription-only and is covered by Medicare and certain commercial insurers, ensuring that patients have access to this crucial technology. In addition to product distribution, AIROS Medical commits to supporting healthcare professionals through clinical education programs, workshops, and live demonstrations at conferences focused on podiatry, vascular care, and wound management.
About AIROS Medical, Inc.
Founded in 2016, AIROS Medical, Inc. specializes in the manufacture of cutting-edge medical technologies aimed at treating peripheral vascular disorders. Its diverse product line includes systems designed to manage lymphedema, chronic venous insufficiency, and now, arterial compression with ARTAIRA. The company’s core mission revolves around enhancing patient care and improving life quality through reliable, advanced medical devices.
As AIROS Medical continues to innovate and expand, they reaffirm their commitment to healthcare excellence and patient well-being. For further details on the ARTAIRA device and other solutions offered by AIROS Medical, visit their official website.
Frequently Asked Questions
What is the ARTAIRA compression device used for?
The ARTAIRA compression device is designed to enhance circulation in patients experiencing symptoms related to Peripheral Arterial Disease (PAD).
How does the ARTAIRA device improve blood flow?
The device utilizes pneumatic compression to inflate and deflate garment chambers on the legs, applying pressure that facilitates better blood circulation.
Who is the ARTAIRA device intended for?
The device is primarily intended for patients suffering from PAD and related conditions that cause poor circulation and painful symptoms in the lower extremities.
Is the ARTAIRA device covered by insurance?
Yes, the ARTAIRA device is a prescription-only product and is reimbursable by Medicare and some commercial health insurers, given the right documentation.
Where can I learn more about AIROS Medical?
More information about AIROS Medical and its products can be found on their official website, which details their commitment to innovation in medical technology.